| 發表年度 | 作者 | 著作名稱 | 著作類別 |
|---|---|---|---|
|
2022
|
陳詠宗
|
Hsin-Yu Chen†, Yung-Tsung Chen†, Kuan-Yi Li, Hsiao-Wen Huang, Yu-Chun Lin, Ming-Ju Chen*(2022)A Heat-Killed Probiotic Mixture Regulates Immune T Cells Balance and IgE Production in House Dust Mite Extraction-Induced Atopic Dermatitis Mice.Microorganisms.
|
期刊論文
|
|
2022
|
陳詠宗
|
Chou-Yi Hsu, Sheng-Che Lin, Yi-Hsuan Wu, Chun-Yi Hu, Yung-Tsung Chen, Yo-Chia Chen*(2022)The Antimicrobial Effects of Bacterial Cellulose Produced by Komagataeibacter intermedius in Promoting Wound Healing in Diabetic Mice.International Journal of Molecular Sciences.
|
期刊論文
|
|
2021
|
陳詠宗
|
YT Chen, AH Hsu, SY Chiou, YC Lin, JS Lin (2021) AB-Kefir reduced body weight and ameliorated inflammation in adipose tissue of obese mice fed a high-fat diet, but not a high-sucrose diet. Nutrients. 13(7), 2182
|
期刊論文
|
|
2021
|
陳詠宗
|
YT Chen, SY Chiou, AH Hsu, YC Lin, JS Lin (2021) Lactobacillus rhamnosus strain LRH05 Intervention Ameliorated Body Weight Gain and Adipose Inflammation by Remodeling the Gut Microbiota in High-Fat Diet-induced Obese Mice. Mol. Nutr. Food. Res. 66(1):e2100348.
|
期刊論文
|
|
2020
|
陳詠宗
|
YC Lin, YT Chen, KY Li, MJ Chen. (2020) Investigating the mechanistic differences of obesity-inducing Lactobacillus kefiranofaciens M1 and anti-obesity Lactobacillus mali APS1 by microbolomics and metabolomics. Front. Microbiol. 11:1454
|
期刊論文
|
|
2018
|
陳詠宗
|
YT Chen, NS Yang, YC Lin, ST Ho, KY Li, JS Lin, JR Liu, MJ Chen (2018) A combination of Lactobacillus mali APS1 and dieting improved the efficacy of obesity treatment via manipulating gut microbiome in mice. Sci. Rep. 8:6153
|
期刊論文
|
|
2018
|
陳詠宗
|
YT Chen, YC Lin, JS Lin, NS Yang, MJ Chen (2018) Sugary kefir strain Lactobacillus mali APS1 ameliorated hepatic steatosis by regulation of SIRT-1/Nrf-2 and gut microbiota in obese rats. Mol. Nutr. Food. Res. 62:1700903
|
期刊論文
|
|
2018
|
陳詠宗
|
YC Lin, YT Chen, MJ Chen (2018) Lack of mutagenicity, genotoxicity and developmental toxicity in safety assessment tests of Lactobacillus mali APS1. PLoS One. 13:e0208881
|
期刊論文
|
|
2017
|
陳詠宗
|
陳明汝、林幼君、陳詠宗。體增重(脂肪)調節功能益生菌之機制探討及應用於動物飼料可行性之評估。農業生技產業季刊 51 2017.09 [民106.09] 頁29-36。
|
專書與其他
|
|
2016
|
陳詠宗
|
林幼君、陳詠宗。發酵畜產品：好菌小尖兵擊退體脂肪。《科學發展》2016年12月，528期，18 ~ 21頁。
|
專書與其他
|
|
2016
|
陳詠宗
|
YC Lin, YT Chen, HH Hsieh, MJ Chen (2016). Effect of Lactobacillus mali APS1 and L. kefiranofaciens M1 on obesity and glucose homeostasis in diet-induced obese mice. J. Funct. Foods. 23:580–9
|
期刊論文
|
|
2011
|
陳詠宗
|
NV Cuong, MF Hsieh, YT Chen, I Liau (2011). Doxorubicin-loaded nanosized micelles of a star-shaped poly(ε-Caprolactone)-Polyphosphoester block co-polymer for treatment of human breast cancer. J. Biomater. Sci. Polym. Ed. 22(11):1409-26
|
期刊論文
|
|
2011
|
陳詠宗
|
CH Chen, NV Cuong, YT Chen, RC So, I Liau, MF Hieh (2011). Overcoming multidrug resistance of breast cancer cells by the micellar doxorubicin nanoparticles of mPEG-PCL-Graft cellulose. J. Nanosci. Nanotechnol. 11(1):53-60
|
期刊論文
|
|
2008
|
陳詠宗
|
MF Hsieh, NV Cuong, CH Chen, YT Chen, JM Yeh (2008). Nano-sized micelles of block copolymers of methoxy poly(ethylene glycol)-poly(epsilon-caprolactone)-graft-2-hydroxyethyl cellulose for doxorubicin delivery. J. Nanosci. Nanotechnol. 8(5):2362-8
|
期刊論文
|
|
2008
|
陳詠宗
|
YT Chen, CH Chen, MF Hsieh, AS Chan, I Liau, WY Tai (2008) Overcoming Multidrug Resistance of Breast Cancer Cells by the Micellar Drug Carriers of mPEG-PCL-graft-cellulose. ICBME 2008. Proceedings 23:1224-7
|
期刊論文
|